CompletedNCT06746441
Psilocybin alone or with CBT for depression
About this title
Read the official source — NCT06746441Medication studyAges 18–70Pakistan
Understand this study
Who was this study for?
Listed age limits: 18 years to 70 years.
- Listed locations
- PeshawarSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: December 1, 2024
- Recruitment status
- Completed
- Enrollment listed in the registry
- 60
- Sponsor
- Khyber Medical University Peshawar
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Behavioural, Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Pakistan
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT06746441
- Official title
Show the full official title
Effect of Psilocybin Only and Psilocybin Assisted Cognitive Behavioral Therapy in the Management of Major Depressive Disorder and Associated Metabolic, Immune, Inflammatory, Neuroplasticity and Electrical Activity Markers: a Randomized Controlled Trial
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Peshawar
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Khyber Medical University Peshawar, a university.
Did this study involve medication?
Yes. The study involved medication, including Psilocybin.
Who was this study for?
Listed age limits: 18 years to 70 years.
